Hormone therapy and cardiovascular risk markers and disease: focus on progestagens

Author： Pedersen Susan H   Lokkegaard Ellen   Ottesen Bent  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.2, Iss.6, 2006-11, pp. : 677-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hormone Replacement Therapy and Cardiovascular Risk

By Chong A-Y.   Lip G.Y.H.  

Treatments in Endocrinology, Vol. 1, Iss. 2, 2002-02 ,pp. : 95-103

Adis International

Access to resources Recommend Favorite

Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease

By Khalil Raouf A  

Future Cardiology, Vol. 3, Iss. 3, 2007-05 ,pp. : 283-300

Future Medicine

Access to resources Recommend Favorite

Hormone replacement therapy and cardiovascular function

By Fisman Enrique Z.   Shapira Itzhak   Tenenbaum Alexander  

Human Reproduction, Vol. 14, Iss. 9, 1999-09 ,pp. : 2418-2419

Oxford University Press

Access to resources Recommend Favorite

Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk

By Cerquetani E   Vitale C   Mercuro G   Fini M   Zoncu S   Rosano GMC  

Gynecological Endocrinology, Vol. 18, Iss. 6, 2004-06 ,pp. : 291-298

Informa Healthcare

Access to resources Recommend Favorite

Scoring the risk in cardiovascular disease

By Hoke Matthias  

Interventional Cardiology, Vol. 5, Iss. 3, 2013-06 ,pp. : 239-241

Future Medicine

Access to resources Recommend Favorite